Yuxin Liu, Minghao Dong, Yunhui Chu, Luoqi Zhou, Yunfan You, Xiaowei Pang, Sheng Yang, Luyang Zhang, Lian Chen, Lifang Zhu, Jun Xiao, Wei Wang, Chuan Qin, Daishi Tian
Chimeric antigen receptor (CAR)-T cell therapy has achieved remarkable success in the treatment of hematological malignancies. Based on the immunomodulatory capability of CAR-T cells, efforts have turned toward exploring their potential in treating autoimmune diseases. Bibliometric analysis of 210 records from 128 academic journals published by 372 institutions in 40 countries/regions indicates a growing number of publications on CAR-T therapy for autoimmune diseases, covering a range of subtypes such as systemic lupus erythematosus, multiple sclerosis, among others...
April 12, 2024: Chinese Medical Journal